Nebulization of Hypoxic hUCMSC-EVs Attenuates Airway Epithelial Barrier Defects in Chronic Asthma Mice by Transferring CAV-1
Nebulization of Hypo-EVs can attenuate airway epithelial barrier defects in asthma by delivering CAV-1 to inhibit p-STAT6 expression and may be used to treat other barrier defect diseases.
Authors
- Xinkai Luo
- Liyang Dong (ORCID: https://orcid.org/0000-0002-2200-784X)
- Xiaowei Xu (ORCID: https://orcid.org/0000-0003-4863-112X)
- Yufei Mao (ORCID: https://orcid.org/0000-0002-4834-561X)
- Ying Wang (ORCID: https://orcid.org/0000-0002-1407-2668)
- Wen Li (ORCID: https://orcid.org/0000-0001-6906-1256)
- Weifeng Gu
- Tingting Zheng (ORCID: https://orcid.org/0000-0002-7331-1040)
- Chaoming Mao (ORCID: https://orcid.org/0000-0002-2014-658X)
Institutions
- Xuzhou Medical College (CN)
- Second People’s Hospital of Huai’an (CN)
Publication Details
- Journal
- International Journal of Nanomedicine
- Published
- 2024-10-01
- DOI
- https://doi.org/10.2147/ijn.s476151
- Citations
- 12
- Primary Topic
- Extracellular vesicles in disease
- Type
- article
- Field-Weighted Citation Impact
- 2.81